Tel : 0086-021-5165-9050 / 0086-15618223367 Email : sales@atkchmemical.com
BI-6727
ATK-00025
98.00%
755038-65-4
C34H50N8O3
618.8126
Article number Size Operate
ATK-00025 10MG 10MG Inquiry
ATK-00025 25MG 25MG Inquiry
Detection information
Purity: 99.99%
Product Details
CAS Number 755038-65-4 Appearance
Catalog NO ATK-00025 MDL Number
Molecular Formula C34H50N8O3 Molecular Weight 618.8126
Boiling Point No data available Melting Point
Flash Poin Density 1.26
Synonyms Volasertib (BI 6727);BI 6727;BI-6727;BI6727 (BI-6727,Volasertib);N-[4-[4-(cyclopropylmethyl)piperazin-1-yl]cyclohexyl]-4-[[(7R)-7-ethyl-5-methyl-6-oxo-8-propan-2-yl-7H-pteridin-2-yl]amino]-3-methoxybenzamide;N-[trans-4-[4-(cyclopropylmethyl)-1-piperazinyl]cyclohexyl]-4-[[(7R)-7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl] amino]-3-methoxyBenzamide;Volasertib;BI6727,Volasertib;UNII-6EM57086EA;SR-03000003275;SCHEMBL738946;NSC757149;DB12062;n-[trans-4-[4-(cyclopropylmethyl)-1-piperazinyl]cyclohexyl]-4-[[(7r)-7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl]amino]-3-methoxybenzamide;IBI;SCHEMBL2169101;NCGC00263087-12;GTPL7947;NCGC00485964-01;Volasertib [USAN];AKOS030257530;DTXSID801099395;s2235;NS00073642;NSC-757149;BI6727;NCGC00263087-02;AKOS005266487;NCGC00263087-15;Benzamide, N-(trans-4-(4-(cyclopropylmethyl)-1-piperazinyl)cyclohexyl)-4-(((7R)-7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl)amino)-3-methoxy-;BENZAMIDE, N-[TRANS-4-[4-(CYCLOPROPYLMETHYL)-1-PIPERAZINYL]CYCLOHEXYL]-4-[[(7R)-7-ETHYL-5,6,7,8-TETRAHYDRO-5-METHYL-8-(1-METHYLETHYL)-6-OXO-2-PTERIDINYL]AMINO]-3-METHOXY-;C34H50N8O3;Q7939986;CS-0274;SMR004702964;BI6727 (Volasertib);SR-03000003275-1;N-(Trans-4-(4-(cyclopropylMethyl)piperazin-1-yl)cyclohexyl)-4-(((R)-7-ethyl-8-isopropyl-5-Methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl)aMino)-3-MethoxybenzaMide;6EM57086EA;N-((1s,4S)-4-(4-(cyclopropylmethyl)piperazin-1-yl)cyclohexyl)-4-(((R)-7-ethyl-8-isopropyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl)amino)-3-methoxybenzamide;755038-65-4;Volasertib(BI6727);D10182;NSC-800965;SCHEMBL21916558;N-{trans-4-[4-(Cyclopropylmethyl)piperazin-1-Yl]cyclohexyl}-4-{[(7r)-7-Ethyl-5-Methyl-8-(1-Methylethyl)-6-Oxo-5,6,7,8-Tetrahydropteridin-2-Yl]amino}-3-Methoxybenzamide;755038-54-1;NCGC00263087-03;AS-16996;BCP9000403;MFCD20926414;HY-12137;Volasertib (USAN);SCHEMBL9888052;MLS006011195;N-[cis-4-[4-(Cyclopropylmethyl)-1-piperazinyl]cyclohexyl]-4-[[(7R)-7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl]amino]-3-methoxybenzamide;BCP02405;Volasertib [USAN:INN];CCG-264952;EX-A1364;SW218140-2;BCPP000341;NSC800965;NCGC00263087-01;CHEMBL1233528;CHEMBL4284151;DTXSID901025694;BDBM50402023;AC-32844;Bi6727(volasertib);VOLASERTIB [WHO-DD];VOLASERTIB [INN];N-((trans)-4-(4-(cyclopropylmethyl)piperazin-1-yl)cyclohexyl)-4-((R)-7-ethyl-8-isopropyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-ylamino)-3-methoxybenzamide
Storage Condition
Safety
GHS Pictogram
Signal Word UN Number
Hazard Statements Class
Precautionary Statements Packing Group
Description
There is currently no product overview available!